These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 37081394

  • 21. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.
    Yang S, Zhou J, Chen Z, Sun Q, Zhang D, Feng Y, Wang X, Sun Y.
    Front Oncol; 2022; 12():934928. PubMed ID: 35992788
    [Abstract] [Full Text] [Related]

  • 22. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.
    Zhou K, Yang J, Li X, Xiong W, Zhang P, Zhang X.
    Front Surg; 2022; 9():893977. PubMed ID: 35784919
    [Abstract] [Full Text] [Related]

  • 23. N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma.
    Regmi P, He ZQ, Lia T, Paudyal A, Li FY.
    Front Genet; 2022; 13():918983. PubMed ID: 35734429
    [Abstract] [Full Text] [Related]

  • 24. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J, Wang H, Yao Y, Wu Z, Chen L, Jin C, Shi Z, Wu C, Hu X.
    Aging (Albany NY); 2022 Jun 29; 14(12):5233-5249. PubMed ID: 35771136
    [Abstract] [Full Text] [Related]

  • 25. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L, Xie R, Lu G.
    Biosci Rep; 2021 Jun 25; 41(6):. PubMed ID: 34027555
    [Abstract] [Full Text] [Related]

  • 26. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ, Zhang J, Xu L, Liu FF.
    World J Gastroenterol; 2018 Aug 14; 24(30):3426-3439. PubMed ID: 30122881
    [Abstract] [Full Text] [Related]

  • 27. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P, Wen DY, Li Q, He Y, Yang H, Chen G.
    Cell Physiol Biochem; 2018 Aug 14; 48(5):1953-1967. PubMed ID: 30092571
    [Abstract] [Full Text] [Related]

  • 28. Establishment of an endoplasmic reticulum stress-associated lncRNAs model to predict prognosis and immunological characteristics in hepatocellular carcinoma.
    Shen X, Wu S, Yang Z, Zhu C.
    PLoS One; 2023 Aug 14; 18(8):e0287724. PubMed ID: 37647290
    [Abstract] [Full Text] [Related]

  • 29. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J, Wu L, Lei X, Shi K, Shi L, Shi Y.
    Bioengineered; 2021 Dec 14; 12(1):673-681. PubMed ID: 33622186
    [Abstract] [Full Text] [Related]

  • 30. A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma.
    Liao LE, Hu DD, Zheng Y.
    Genes (Basel); 2020 Aug 08; 11(8):. PubMed ID: 32784402
    [Abstract] [Full Text] [Related]

  • 31. WDR4 promotes HCC pathogenesis through N7-methylguanosine by regulating and interacting with METTL1.
    Dong R, Wang C, Tang B, Cheng Y, Peng X, Yang X, Ni B, Li J.
    Cell Signal; 2024 Jun 08; 118():111145. PubMed ID: 38493882
    [Abstract] [Full Text] [Related]

  • 32. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y, Wei X, Han Q, Le J, Ma Y, Lin X, Xu Y, Liu N, Wang X, Kong X, Gu J, Tong Y, Wu H.
    BMC Cancer; 2021 Oct 30; 21(1):1165. PubMed ID: 34717566
    [Abstract] [Full Text] [Related]

  • 33. N7-methylguanosine-related lncRNAs: Distinction between hot and cold tumors and construction of predictive models in colon adenocarcinoma.
    Cheng Z, Wang J, Xu Y, Jiang T, Xue Z, Li S, Zhao Y, Song H, Song J.
    Front Oncol; 2022 Oct 30; 12():951452. PubMed ID: 36185235
    [Abstract] [Full Text] [Related]

  • 34. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z, Peng B, Liang Q, Chen X, Cai Y, Zeng S, Gao K, Wang X, Yi Q, Gong Z, Yan Y.
    Front Immunol; 2021 Oct 30; 12():719175. PubMed ID: 34603293
    [Abstract] [Full Text] [Related]

  • 35. Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma.
    Liu C, Wu S, Lai L, Liu J, Guo Z, Ye Z, Chen X.
    BMC Bioinformatics; 2023 Jan 03; 24(1):4. PubMed ID: 36597032
    [Abstract] [Full Text] [Related]

  • 36. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
    Liu P, Dong C, Shi H, Yan Z, Zhang J, Liu J.
    J Gastrointest Oncol; 2022 Dec 03; 13(6):3169-3182. PubMed ID: 36636051
    [Abstract] [Full Text] [Related]

  • 37. Risk scoring based on expression of long non‑coding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis.
    Ye J, Wu S, Pan S, Huang J, Ge L.
    Oncol Rep; 2020 May 03; 43(5):1451-1466. PubMed ID: 32323856
    [Abstract] [Full Text] [Related]

  • 38. Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma.
    Chen W, Shu K, Cai C, Ding J, Zhang X, Zhang W, Wang K.
    Biosci Rep; 2023 Sep 27; 43(9):. PubMed ID: 37584192
    [Abstract] [Full Text] [Related]

  • 39. N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma.
    Ming J, Wang C.
    Front Genet; 2022 Sep 27; 13():871899. PubMed ID: 35495133
    [Abstract] [Full Text] [Related]

  • 40. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Wang J, Pu J, Yao T, Lu X, Deng Y.
    J Cell Physiol; 2019 Jun 27; 234(6):8709-8716. PubMed ID: 30417366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.